Home LiteratureArticle Details
PMID: 24157548 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Genome engineering using the CRISPR-Cas9 system.

Nature protocols ·Vol. 8 ·No. 11 ·2013-11-00 ·Pages 2281-2308

Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F

Abstract

Targeted nucleases are powerful tools for mediating genome alteration with high precision. The RNA-guided Cas9 nuclease from the microbial clustered regularly interspaced short palindromic repeats (CRISPR) adaptive immune system can be used to facilitate efficient genome engineering in eukaryotic cells by simply specifying a 20-nt targeting sequence within its guide RNA. Here we describe a set of tools for Cas9-mediated genome editing via nonhomologous end joining (NHEJ) or homology-directed repair (HDR) in mammalian cells, as well as generation of modified cell lines for downstream functional studies. To minimize off-target cleavage, we further describe a double-nicking strategy using the Cas9 nickase mutant with paired guide RNAs. This protocol provides experimentally derived guidelines for the selection of target sites, evaluation of cleavage efficiency and analysis of off-target activity. Beginning with target design, gene modifications can be achieved within as little as 1-2 weeks, and modified clonal cell lines can be derived within 2-3 weeks.

MeSH Terms
Base Sequence Cell Culture Techniques Cell Line Clustered Regularly Interspaced Short Palindromic Repeats DNA End-Joining Repair DNA Mutational Analysis DNA Repair Deoxyribonucleases/chemistry,genetics Genetic Engineering/methods Genome Genotyping Techniques HEK293 Cells Humans Molecular Sequence Data Mutagenesis Transfection
Chemicals
Deoxyribonucleases
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Ran F Ann
Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA. | McGovern Institute for Brain Research, Cambridge, Massachusetts, USA. | Department of Brain and Cognitive Sciences, MIT, Cambridge, Massachusetts, USA. | Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA. | Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts, USA.
Hsu Patrick D
Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA. | McGovern Institute for Brain Research, Cambridge, Massachusetts, USA. | Department of Brain and Cognitive Sciences, MIT, Cambridge, Massachusetts, USA. | Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA. | Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts, USA.
Wright Jason
Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA.
Agarwala Vineeta
Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA. | Program in Biophysics, Harvard University, MIT, Cambridge, Massachusetts, USA. | Harvard-MIT Division of Health Sciences and Technology, MIT, Cambridge, Massachusetts, USA.
Scott David A
Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA. | McGovern Institute for Brain Research, Cambridge, Massachusetts, USA. | Department of Brain and Cognitive Sciences, MIT, Cambridge, Massachusetts, USA. | Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA.
Zhang Feng
Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA. | McGovern Institute for Brain Research, Cambridge, Massachusetts, USA. | Department of Brain and Cognitive Sciences, MIT, Cambridge, Massachusetts, USA. | Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA.
References (63)
63 references, click to expand
  1. Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease.
    Genetics. 2013 Aug;194(4):1029-35 PMID: 23709638
  2. Expanding small RNA interference.
    Nat Biotechnol. 2002 May;20(5):446-8 PMID: 11981553
  3. A ligation-independent cloning technique for high-throughput assembly of transcription activator–like effector genes.
    Nat Biotechnol. 2013 Jan;31(1):76-81 PMID: 23242165
  4. Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors.
    Hum Gene Ther. 2011 Sep;22(9):1143-53 PMID: 21476867
  5. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA.
    Science. 2008 Dec 19;322(5909):1843-5 PMID: 19095942
  6. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription.
    Nat Biotechnol. 2011 Feb;29(2):149-53 PMID: 21248753
  7. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations.
    Cell. 2011 Jul 22;146(2):318-31 PMID: 21757228
  8. A protocol for constructing gene targeting vectors: generating knockout mice for the cadherin family and beyond.
    Nat Protoc. 2008;3(6):1056-76 PMID: 18546598
  9. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells.
    Nat Biotechnol. 2013 Sep;31(9):822-6 PMID: 23792628
  10. RNA-guided human genome engineering via Cas9.
    Science. 2013 Feb 15;339(6121):823-6 PMID: 23287722
  11. The length of homology required for gene targeting in embryonic stem cells.
    Mol Cell Biol. 1991 Nov;11(11):5586-91 PMID: 1656234
  12. Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells.
    Nucleic Acids Res. 2004 Jul 13;32(12):3683-8 PMID: 15252152
  13. Breaking the code of DNA binding specificity of TAL-type III effectors.
    Science. 2009 Dec 11;326(5959):1509-12 PMID: 19933107
  14. CRISPR/Cas system and its role in phage-bacteria interactions.
    Annu Rev Microbiol. 2010;64:475-93 PMID: 20528693
  15. Efficient genome editing in zebrafish using a CRISPR-Cas system.
    Nat Biotechnol. 2013 Mar;31(3):227-9 PMID: 23360964
  16. High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases.
    Nat Methods. 2011 Jul 17;8(9):753-5 PMID: 21765410
  17. Efficient TALEN-mediated gene knockout in livestock.
    Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17382-7 PMID: 23027955
  18. A rapid and general assay for monitoring endogenous gene modification.
    Methods Mol Biol. 2010;649:247-56 PMID: 20680839
  19. Knockout rats via embryo microinjection of zinc-finger nucleases.
    Science. 2009 Jul 24;325(5939):433 PMID: 19628861
  20. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting.
    Nucleic Acids Res. 2011 Jul;39(12):e82 PMID: 21493687
  21. An improved zinc-finger nuclease architecture for highly specific genome editing.
    Nat Biotechnol. 2007 Jul;25(7):778-85 PMID: 17603475
  22. Genome editing with engineered zinc finger nucleases.
    Nat Rev Genet. 2010 Sep;11(9):636-46 PMID: 20717154
  23. RNA-guided editing of bacterial genomes using CRISPR-Cas systems.
    Nat Biotechnol. 2013 Mar;31(3):233-9 PMID: 23360965
  24. A TALE nuclease architecture for efficient genome editing.
    Nat Biotechnol. 2011 Feb;29(2):143-8 PMID: 21179091
  25. Targeting DNA double-strand breaks with TAL effector nucleases.
    Genetics. 2010 Oct;186(2):757-61 PMID: 20660643
  26. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.
    Cell. 2013 May 9;153(4):910-8 PMID: 23643243
  27. FLASH assembly of TALENs for high-throughput genome editing.
    Nat Biotechnol. 2012 May;30(5):460-5 PMID: 22484455
  28. Cleavage of phage DNA by the Streptococcus thermophilus CRISPR3-Cas system.
    PLoS One. 2012;7(7):e40913 PMID: 22911717
  29. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.
    Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):E2579-86 PMID: 22949671
  30. DNA targeting specificity of RNA-guided Cas9 nucleases.
    Nat Biotechnol. 2013 Sep;31(9):827-32 PMID: 23873081
  31. A transcription activator-like effector toolbox for genome engineering.
    Nat Protoc. 2012 Jan 05;7(1):171-92 PMID: 22222791
  32. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases.
    Nat Biotechnol. 2008 Jul;26(7):808-16 PMID: 18587387
  33. A simple cipher governs DNA recognition by TAL effectors.
    Science. 2009 Dec 11;326(5959):1501 PMID: 19933106
  34. Gene conversion tracts from double-strand break repair in mammalian cells.
    Mol Cell Biol. 1998 Jan;18(1):93-101 PMID: 9418857
  35. Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination.
    Nature. 1985 Sep 19-25;317(6034):230-4 PMID: 2995814
  36. CRISPR provides acquired resistance against viruses in prokaryotes.
    Science. 2007 Mar 23;315(5819):1709-12 PMID: 17379808
  37. CRISPR/Cas, the immune system of bacteria and archaea.
    Science. 2010 Jan 8;327(5962):167-70 PMID: 20056882
  38. Generation of gene-modified mice via Cas9/RNA-mediated gene targeting.
    Cell Res. 2013 May;23(5):720-3 PMID: 23545779
  39. Targeted genome editing across species using ZFNs and TALENs.
    Science. 2011 Jul 15;333(6040):307 PMID: 21700836
  40. Translocation capture sequencing: a method for high throughput mapping of chromosomal rearrangements.
    J Immunol Methods. 2012 Jan 31;375(1-2):176-81 PMID: 22033343
  41. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.
    Nat Biotechnol. 2013 Mar;31(3):230-2 PMID: 23360966
  42. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression.
    Cell. 2013 Feb 28;152(5):1173-83 PMID: 23452860
  43. Processing-independent CRISPR RNAs limit natural transformation in Neisseria meningitidis.
    Mol Cell. 2013 May 23;50(4):488-503 PMID: 23706818
  44. High frequency targeting of genes to specific sites in the mammalian genome.
    Cell. 1986 Feb 14;44(3):419-28 PMID: 3002636
  45. Performance comparison of benchtop high-throughput sequencing platforms.
    Nat Biotechnol. 2012 May;30(5):434-9 PMID: 22522955
  46. Dissecting neural function using targeted genome engineering technologies.
    ACS Chem Neurosci. 2012 Aug 15;3(8):603-10 PMID: 22896804
  47. Targeted mutagenesis in the silkworm Bombyx mori using zinc finger nuclease mRNA injection.
    Insect Biochem Mol Biol. 2010 Oct;40(10):759-65 PMID: 20692340
  48. CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation.
    Annu Rev Genet. 2011;45:273-97 PMID: 22060043
  49. Small CRISPR RNAs guide antiviral defense in prokaryotes.
    Science. 2008 Aug 15;321(5891):960-4 PMID: 18703739
  50. A TALEN genome-editing system for generating human stem cell-based disease models.
    Cell Stem Cell. 2013 Feb 7;12(2):238-51 PMID: 23246482
  51. Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA).
    Nat Methods. 2011 Jan;8(1):67-9 PMID: 21151135
  52. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli.
    Nucleic Acids Res. 2011 Nov;39(21):9275-82 PMID: 21813460
  53. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA.
    Nature. 2010 Nov 4;468(7320):67-71 PMID: 21048762
  54. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
    Science. 2012 Aug 17;337(6096):816-21 PMID: 22745249
  55. Evolution and classification of the CRISPR-Cas systems.
    Nat Rev Microbiol. 2011 Jun;9(6):467-77 PMID: 21552286
  56. Multiplex genome engineering using CRISPR/Cas systems.
    Science. 2013 Feb 15;339(6121):819-23 PMID: 23287718
  57. Chimeric nucleases stimulate gene targeting in human cells.
    Science. 2003 May 2;300(5620):763 PMID: 12730593
  58. Heritable genome editing in C. elegans via a CRISPR-Cas9 system.
    Nat Methods. 2013 Aug;10(8):741-3 PMID: 23817069
  59. Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos.
    Cell Res. 2013 Apr;23(4):465-72 PMID: 23528705
  60. RNA-programmed genome editing in human cells.
    Elife. 2013 Jan 29;2:e00471 PMID: 23386978
  61. Genetic engineering of human pluripotent cells using TALE nucleases.
    Nat Biotechnol. 2011 Jul 07;29(8):731-4 PMID: 21738127
  62. Non-transgenic genome modifications in a hemimetabolous insect using zinc-finger and TAL effector nucleases.
    Nat Commun. 2012;3:1017 PMID: 22910363
  63. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.
    Cell. 2013 Sep 12;154(6):1380-9 PMID: 23992846
Article Info
Journal
Nature protocols
Abbr.
Nat Protoc
ISSN
1750-2799
DOI
10.1038/nprot.2013.143
Published
2013-11-00
Epub
2013-00-24
Pages
2281-2308
Language
English
Region
England
NLM ID
101284307
PMCID
PMC3969860
Subset
IM
Grants
NIDDK NIH HHS · 1R01-DK097768 · United States
NIGMS NIH HHS · T32 GM007753 · United States
NIMH NIH HHS · DP1 MH100706 · United States
NIGMS NIH HHS · T32GM007753 · United States
NCCDPHP CDC HHS · 1DP1-MH100706 · United States
NIDDK NIH HHS · F32 DK096822 · United States
NIGMS NIH HHS · T32GM008313 · United States
NIDDK NIH HHS · R01 DK097768 · United States
NIGMS NIH HHS · T32 GM008313 · United States
External Links
PubMed source DOI: 10.1038/nprot.2013.143 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2